NEUBERGER BERMAN GROUP LLC
Position in CATX — Perspective Therapeutics, Inc.
CIK 1465109
NEW YORK, NY
Position in CATX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$52,117
New position
Shares Held
15,284
first reported quarter
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 130 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Medical Devices
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $2,064,804,888 across 41 Medical Devices names. CATX ranks #38 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HAE |
Haemonetics Corp
|
4,179,443 | $313,458,225 | |
| 2 | EW |
Edwards Lifesciences Corp
|
2,886,953 | $261,153,767 | |
| 3 | ABT |
Abbott Laboratories
|
2,558,111 | $232,122,991 | |
| 4 | SYK |
Stryker Corp
|
672,964 | $211,875,985 | |
| 5 | MDT |
Medtronic plc
|
2,468,323 | $193,096,907 | |
| 6 | NEOG |
Neogen Corp
|
16,570,795 | $148,971,446 | |
| 7 | UFPT |
Ufp Technologies Inc
|
537,038 | $142,384,884 | |
| 8 | PEN |
Penumbra Inc
|
438,553 | $138,473,109 |
All Filings in CATX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,117 | 15,284 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||